Editas Medicine, Inc.

NASDAQ:EDIT

6.04 (USD) • At close June 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014
Revenue 78.12319.71225.54490.73220.53131.93713.7286.0531.6290
Cost of Revenue 6.0646.3375.053157.99696.89800000
Gross Profit 72.05913.37520.491-67.264-76.36731.93713.7286.0531.6290
Gross Profit Ratio 0.9220.6790.802-0.741-3.7211110
Reseach & Development Expenses 171.587174.958142.507157.99696.89890.65483.15956.97918.8465.073
General & Administrative Expenses 69.65370.70476.18367.57664.55555.0150.50246.26218.0957.65
Selling & Marketing Expenses 0000000000
SG&A 69.65370.70476.18367.57664.55555.0150.50246.26218.0957.65
Other Expenses -1.6041.293-1.69816.259-0.1370.3280.587-0.057-37.445-0.928
Operating Expenses 241.24245.662218.69225.572161.453145.664133.661103.24136.94112.723
Operating Income -169.181-225.95-193.146-134.84-140.922-113.727-119.933-97.188-35.312-12.723
Operating Income Ratio -2.166-11.463-7.561-1.486-6.864-3.561-8.736-16.056-21.6770
Total Other Income Expenses Net 15.9625.5180.64418.8647.1760.3280.587-0.057-37.445-0.928
Income Before Tax -153.219-220.432-192.502-115.976-133.746-109.954-120.324-97.183-72.9-13.685
Income Before Tax Ratio -1.961-11.183-7.536-1.278-6.514-3.443-8.765-16.055-44.7510
Income Tax Expense 0-16.08-7.395-6.564-10.28-3.117-1.118-1.321-37.773-0.894
Net Income -153.219-204.352-185.107-109.412-123.466-109.954-120.324-97.183-72.9-13.685
Net Income Ratio -1.961-10.367-7.247-1.206-6.014-3.443-8.765-16.055-44.7510
EPS -2.02-2.98-2.74-1.87-2.47-2.33-2.98-3.02-2.04-0.89
EPS Diluted -2.02-2.98-2.74-1.87-2.47-2.33-2.98-3.02-2.04-0.89
EBITDA -163.117-225.95-193.146-134.84-141.059-113.399-119.346-97.245-72.757-13.494
EBITDA Ratio -2.088-11.463-7.561-1.486-6.871-3.551-8.694-16.066-44.6640